RAPT Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
RAPT Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • RAPT Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$29.3M, a 3.41% decline year-over-year.
  • RAPT Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$129M, a 21.6% decline year-over-year.
  • RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$127M, a 48.1% decline from 2022.
  • RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$85.8M, a 24% decline from 2021.
  • RAPT Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$69.2M, a 30.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$127M -$41.3M -48.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$85.8M -$16.6M -24% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$69.2M -$16M -30.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$53.2M -$9.59M -22% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$43.6M -$6.68M -18.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$36.9M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.